Success Metrics

Active Trials
0(0%)

Phase Distribution

Ph not_applicable
1
33%
Ph phase_2
1
33%
Ph phase_4
1
33%

Phase Distribution

0

Early Stage

1

Mid Stage

1

Late Stage

Phase Distribution3 total trials
Phase 2Efficacy & side effects
1(33.3%)
Phase 4Post-market surveillance
1(33.3%)
N/ANon-phased studies
1(33.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

0.0%

0 of 1 finished

Non-Completion Rate

100.0%

1 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Active(2)
Terminated(1)

Detailed Status

Not yet recruiting2
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
N/A
Most Advanced
Phase 4

Trials by Phase

Phase 21 (33.3%)
Phase 41 (33.3%)
N/A1 (33.3%)

Trials by Status

not_yet_recruiting267%
withdrawn133%

Recent Activity

0 active trials
Showing 3 of 3
not_yet_recruitingphase_2

Conversion Surgery for Gastric Cancer With Peritoneal Metastases (CONVERGENCE)

NCT07241715
not_yet_recruitingphase_4

Genotype-Driven Neoadjuvant Therapy for Locally Advanced Thyroid Cancer: A Real-World Cohort Study

NCT07010393
withdrawnnot_applicable

Conversion Surgery in Stage IV or Unresectable Gastric Cancer

NCT03366961

Clinical Trials (3)

Showing 3 of 3 trials
NCT07241715Phase 2

Conversion Surgery for Gastric Cancer With Peritoneal Metastases (CONVERGENCE)

Not Yet Recruiting
NCT07010393Phase 4

Genotype-Driven Neoadjuvant Therapy for Locally Advanced Thyroid Cancer: A Real-World Cohort Study

Not Yet Recruiting
NCT03366961Not Applicable

Conversion Surgery in Stage IV or Unresectable Gastric Cancer

Withdrawn

All 3 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
3